The Scientist

» drug development, immunology and neuroscience

Most Recent

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

image: Molecular Fingerprint Predicts Flu Shot Response

Molecular Fingerprint Predicts Flu Shot Response

By | January 4, 2016

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

0 Comments

image: Book Excerpt from <em>NeuroLogic</em>

Book Excerpt from NeuroLogic

By | January 1, 2016

In the introduction to the book, author Eliezer J. Sternberg illustrates what can happen when the brain’s processing centers are damaged.

0 Comments

image: Christie Fowler: Addicted to Research

Christie Fowler: Addicted to Research

By | January 1, 2016

Assistant Professor, Department of Neurobiology and Behavior University of California, Irvine. Age: 39

0 Comments

image: Flavor Savors

Flavor Savors

By | January 1, 2016

Odors experienced via the mouth are essential to our sense of taste.

2 Comments

image: Logically Illogical

Logically Illogical

By | January 1, 2016

The most bizarre behaviors often make perfect sense in the minds of the mentally ill.

3 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Practical Proteomes

Practical Proteomes

By | January 1, 2016

Cell type–specific proteomic analyses are now possible from paraffin-embedded tissues.

0 Comments

image: The Age of Pharmabrewing

The Age of Pharmabrewing

By | January 1, 2016

We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.

0 Comments

Popular Now

  1. Students Study Their Own Microbiomes
  2. Single Bacterial Species Improves Autism-Like Behavior in Mice
  3. Illustrating #FieldworkFails
  4. Transmissible Cancers Plague Mollusks
Biosearch Technologies